Ali Mortazavi
PersonHeard in 1 episode across 1 show since Oct 2026
Ali Mortazavi is a biotechnology executive and investor known for leading RNA interference (RNAi) biotechnology companies. He holds a Ph.D. in biology and has written about developments in biotechnology, including CRISPR.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
Email alert
Email me when Ali Mortazavi comes up on a podcast
One email a week at most, with the new episodes that mention Ali Mortazavi. Free, no account needed, unsubscribe in one click.
What Ali Mortazavi has said on podcasts
1 statement
AI-enabled biotech infrastructure may make clinical trials broadly accessible.
“almost anyone can do a clinical trial”
Open the episode · Episode 200 - October 23, 2026Listen at 1:02:24
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Ali Mortazavi, newest first